Zai Lab Ltd: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Zai Lab Ltd Unternehmen

Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Zai Lab Ltd Informationen



BörsenkürzelZLAB

Name des UnternehmensZai Lab Ltd

IPO-datumSep 28, 2020

CEODu (Ying)

Anzahl der mitarbeiter1869

WertpapierartDepository Receipt

GeschäftsjahresendeSep 28

AddresseBuilding B, 899 Halei Road, Pudong

StadtSHANGHAI

BörseNASDAQ OMX - NASDAQ BASIC

LandChina

Postleitzahl201203

Telefon862161632588

Websitehttps://www.zailaboratory.com/

BörsenkürzelZLAB

IPO-datumSep 28, 2020

CEODu (Ying)

Führungskräfte von Zai Lab Ltd



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Joshua L. Smiley

President, Chief Operating Officer

117.60K

+22.60%

Dr. John David Diekman, Ph.D.

Lead Independent Director

99.77K

+10.86%

Mr. William David (Bill) Lis

Independent Director

35.11K

-8.50%

Dr. Yajing Chen, Ph.D.

Chief Financial Officer

19.15K

-4.46%

Dr. Ying (Samantha) Du, Ph.D.

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Ms. Leung (Nisa Bernice) Wing-Yu

Independent Director

--

Mr. Peter Karl Wirth, J.D.

Independent Director

--

Mr. Leon Oliver (Lonnie) Moulder, Jr.

Independent Director

--

Mr. Frazor Titus Edmondson, J.D.

Company Secretary, Chief Legal Officer

--

Mr. Scott W. Morrison, CPA

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Joshua L. Smiley

President, Chief Operating Officer

117.60K

+22.60%

Dr. John David Diekman, Ph.D.

Lead Independent Director

99.77K

+10.86%

Mr. William David (Bill) Lis

Independent Director

35.11K

-8.50%

Dr. Yajing Chen, Ph.D.

Chief Financial Officer

19.15K

-4.46%

Dr. Ying (Samantha) Du, Ph.D.

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Ms. Leung (Nisa Bernice) Wing-Yu

Independent Director

--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

ZEJULA

189.04M

41.35%

VYVGART

94.20M

20.60%

NUZYRA

60.84M

13.31%

Optune

48.33M

10.57%

QINLOCK

35.61M

7.79%

Andere

29.17M

6.38%

Nach RegionUSD

Name

Umsatz

Anteil

China (Mainland)

460.16M

0.00%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

ZEJULA

189.04M

41.35%

VYVGART

94.20M

20.60%

NUZYRA

60.84M

13.31%

Optune

48.33M

10.57%

QINLOCK

35.61M

7.79%

Andere

29.17M

6.38%

Aktionärsstatistik

Aktualisiert: Thu, May 14

Aktionäre

Aktionärstypen

Aktionäre

Anteil

RTW Investments L.P.

6.19%

RA Capital Management, LP

5.11%

Norges Bank Investment Management (NBIM)

3.42%

Frazier Life Sciences Management, L.P.

1.69%

ClearBridge Investments, LLC

1.61%

Andere

81.97%

Aktionäre

Anteil

RTW Investments L.P.

6.19%

RA Capital Management, LP

5.11%

Norges Bank Investment Management (NBIM)

3.42%

Frazier Life Sciences Management, L.P.

1.69%

ClearBridge Investments, LLC

1.61%

Andere

81.97%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor/Hedge Fund

11.71%

Investment Advisor

5.60%

Venture Capital

5.36%

Hedge Fund

4.22%

Sovereign Wealth Fund

3.42%

Individual Investor

1.91%

Private Equity

1.69%

Research Firm

1.50%

Pension Fund

0.05%

Andere

64.54%

Institutionelle Beteiligung



Aktualisiert: Wed, Apr 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q4

280

37.42M

42.38%

--

2026Q1

352

37.82M

33.67%

-10.78M

2025Q4

370

44.73M

39.84%

-12.84M

2025Q3

372

46.61M

41.70%

-15.37M

2025Q2

394

60.58M

54.15%

-11.96M

2025Q1

453

59.51M

53.68%

-14.18M

2024Q4

446

60.80M

55.47%

-4.29M

2024Q3

439

51.45M

51.99%

-10.14M

2024Q2

454

47.04M

47.66%

-14.67M

2024Q1

465

46.22M

46.47%

-13.77M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

RTW Investments L.P.

6.96M

6.14%

+4.67M

+203.71%

Dec 31, 2025

Norges Bank Investment Management (NBIM)

3.84M

3.39%

+3.84M

--

Dec 31, 2025

Frazier Life Sciences Management, L.P.

1.90M

1.68%

+275.00K

+16.90%

Dec 31, 2025

ClearBridge Investments, LLC

1.81M

1.59%

-1.71M

-48.63%

Dec 31, 2025

Citadel Advisors LLC

1.69M

1.49%

+700.80K

+71.00%

Dec 31, 2025

Fidelity Management & Research Company LLC

1.44M

1.27%

-2.84M

-66.32%

Dec 31, 2025

Baron Capital Management, Inc.

1.42M

1.25%

+46.76K

+3.41%

Dec 31, 2025

Adar1 Capital Management LLC

1.25M

1.1%

+377.74K

+43.48%

Dec 31, 2025

Du (Ying Samantha)

1.06M

0.94%

+145.74K

+15.88%

Mar 11, 2026

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

Tema Oncology ETF

1.67%

ALPS Medical Breakthroughs ETF

1.19%

Virtus LifeSci Biotech Products ETF

0.97%

Invesco Golden Dragon China ETF

0.58%

National Security Emerging Markets Index ETF

0.39%

iShares Biotechnology ETF

0.18%

Capital Group New Geography Equity ETF

0.15%

ProShares Ultra Nasdaq Biotechnology

0.12%

Invesco Nasdaq Biotechnology ETF

0.12%

ActivePassive International Equity ETF

0.03%

Tema Oncology ETF

Anteil1.67%

ALPS Medical Breakthroughs ETF

Anteil1.19%

Virtus LifeSci Biotech Products ETF

Anteil0.97%

Invesco Golden Dragon China ETF

Anteil0.58%

National Security Emerging Markets Index ETF

Anteil0.39%

iShares Biotechnology ETF

Anteil0.18%

Capital Group New Geography Equity ETF

Anteil0.15%

ProShares Ultra Nasdaq Biotechnology

Anteil0.12%

Invesco Nasdaq Biotechnology ETF

Anteil0.12%

ActivePassive International Equity ETF

Anteil0.03%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten